“Plaque Psoriasis Pipeline Insight, 2022” report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth prospects across the Plaque Psoriasis Market.
The Plaque Psoriasis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.
The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.
Plaque Psoriasis Pipeline Analysis
The report provides insights into:
-
The report provides detailed insights about emerging therapies for the treatment of Plaque Psoriasis and the aggregate therapies developed by major pharma companies.
-
It accesses the different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Plaque Psoriasis Treatment.
-
It outlines the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
-
The report evaluates the drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
-
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Plaque Psoriasis market.
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Learn How the Ongoing Clinical & Commercial Activities will Affect the Plaque Psoriasis Therapeutic Segment:
https://www.delveinsight.com/sample-request/plaque-psoriasis-pipeline-insight
DelveInsight’s Report covers around 75+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Plaque Psoriasis Therapeutics Landscape
There are approx. 75+ key companies which are developing therapies for Plaque Psoriasis. Currently, Arcutis Biotherapeutics has its Plaque Psoriasis drug candidates in the most advanced stage (preregistration) of clinical development.
Some of the key companies in the Plaque Psoriasis Therapeutic Market include:
Arcutis Biotherapeutics, Affibody, Akeso Biopharma, Dong-A ST Co., Ltd., DelArrivo, Inc., Bristol-Myers Squibb, Bio-Thera Solutions, Janssen Research & Development, LLC, Meiji Pharma USA Inc., Aldeyra Therapeutics, Inc., Amgen, Bioeq GmbH, Can-Fite Biopharma, Hangzhou Highlightll Pharmaceutical Co., Ltd, Nimbus Therapeutics, Sun Pharmaceutical Industries, Jiangsu Hengrui Medicine, Biocon, Pfizer, Ono Pharmaceutical, GC Cell Corporation, Suzhou Zelgen Biopharmaceuticals, Aurigene Discovery Technologies Limited, Celltrion, Tianjin Hemay Pharmaceutical Co., Ltd, Innovent Biologics (Suzhou) Co. Ltd., Sinocelltech, Azora Therapeutics, and many others
Plaque Psoriasis Emerging Drugs Covered in the report include:
• ARQ-151: Arcutis Biotherapeutics
• ABY-035: Affibody
• AK101: Akeso Biopharma
And many others
Request the Sample PDF to Get a Better Understanding of the Emerging Drugs and Key Companies:
https://www.delveinsight.com/sample-request/plaque-psoriasis-pipeline-insight
Table of Content (TOC)
1. Report Introduction
2. Executive Summary
3. Plaque Psoriasis Current Treatment Patterns
4. Plaque Psoriasis – DelveInsight’s Analytical Perspective
5. Therapeutic Assessment
6. Plaque Psoriasis Late Stage Products (Phase-III)
7. Plaque Psoriasis Mid-Stage Products (Phase-II)
8. Plaque Psoriasis Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Plaque Psoriasis Discontinued Products
13. Plaque Psoriasis Product Profiles
14. Key Companies in the Plaque Psoriasis Market
15. Key Products in the Plaque Psoriasis Therapeutics Segment
16. Dormant and Discontinued Products
17. Plaque Psoriasis Unmet Needs
18. Plaque Psoriasis Future Perspectives
19. Plaque Psoriasis Analyst Review
20. Appendix
21. Report Methodology
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report:
https://www.delveinsight.com/sample-request/plaque-psoriasis-pipeline-insight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports By DelveInsight
Wide Neck Bifurcation Intracranial Aneurysms Market
“Wide Neck Bifurcation Intracranial Aneurysms Market” research report provides a detailed overview of the historical and forecasted epidemiology as well as the Wide-Neck Bifurcation Intracranial Aneurysms Market size, share, and trends in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan). Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
